Triple

T19157355
Position Surface form Disambiguated ID Type / Status
Subject Isentress E468958 entity
Predicate target P860 FINISHED
Object HIV-1 integrase NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: HIV-1 integrase | Statement: [Isentress, target, HIV-1 integrase]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: HIV-1 integrase
Context triple: [Isentress, target, HIV-1 integrase]
  • A. HIV-1 integrase chosen
    HIV-1 integrase is a viral enzyme that inserts HIV-1’s genetic material into the host cell’s DNA, making it a key target for antiretroviral drugs.
  • B. HIV-1 reverse transcriptase
    HIV-1 reverse transcriptase is a viral enzyme that converts the HIV-1 RNA genome into DNA, making it a key target for antiretroviral drugs used in HIV treatment.
  • C. HCV NS5B RNA-dependent RNA polymerase
    HCV NS5B RNA-dependent RNA polymerase is the viral enzyme in hepatitis C virus responsible for replicating its RNA genome and a key target for direct-acting antiviral drugs.
  • D. phiC31 integrase system
    The phiC31 integrase system is a site-specific recombination tool widely used in genetic engineering to insert DNA precisely into defined genomic locations.
  • E. HIV-1
    HIV-1 is the primary virus responsible for the global HIV/AIDS pandemic, characterized by its rapid mutation and attack on the human immune system’s CD4+ T cells.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8dd084ff48190ac0f8c46ee722629 completed April 10, 2026, 11:20 a.m.
NER Named-entity recognition batch_69e5eeba91a081909c04d61d6117da06 completed April 20, 2026, 9:15 a.m.
Created at: April 10, 2026, 12:06 p.m.